Literature DB >> 10872444

Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes.

J M McIntosh1, A D Santos, B M Olivera.   

Abstract

The venoms of predatory cone snails represent a rich combinatorial-like library of evolutionarily selected, neuropharmacologically active peptides. A major fraction of the venom components are conotoxins--small, disulfide-rich peptides that potently and specifically target components of the neuromuscular system, particularly ligand- and voltage-gated ion channels. This review focuses on Conus peptides, which act at nicotinic acetylcholine receptors. These nicotinic antagonist peptides from Conus are broadly divided into two groups: those that act at the neuromuscular junction and those that act at subtypes of neuronal nicotinic acetylcholine receptors. The latter include peptides specific for the alpha 7, alpha 3 beta 2, and alpha 3 beta 4 nicotinic receptor subtypes. The degree of specificity exhibited by these peptides is remarkable, particularly given their relatively small size. As a group the nicotinic acetylcholine receptor-targeted Conus peptides represent an increasingly well-defined set of tools for probing the structure, function, and physiological role of nicotinic acetylcholine receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10872444     DOI: 10.1146/annurev.biochem.68.1.59

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  56 in total

1.  A comparative study on selectivity of alpha-conotoxins GI and ImI using their synthetic analogues and derivatives.

Authors:  Igor E Kasheverov; Maxim N Zhmak; Innokenty V Maslennikov; Yuri N Utkin; Victor I Tsetlin
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  Structural and ligand recognition characteristics of an acetylcholine-binding protein from Aplysia californica.

Authors:  Scott B Hansen; Todd T Talley; Zoran Radic; Palmer Taylor
Journal:  J Biol Chem       Date:  2004-04-06       Impact factor: 5.157

3.  Solution conformation of alpha-conotoxin GIC, a novel potent antagonist of alpha3beta2 nicotinic acetylcholine receptors.

Authors:  Seung-Wook Chi; Do-Hyoung Kim; Baldomero M Olivera; J Michael McIntosh; Kyou-Hoon Han
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

Review 4.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

5.  Protein folding determinants: structural features determining alternative disulfide pairing in alpha- and chi/lambda-conotoxins.

Authors:  Tse Siang Kang; Zoran Radić; Todd T Talley; Seetharama D S Jois; Palmer Taylor; R Manjunatha Kini
Journal:  Biochemistry       Date:  2007-02-22       Impact factor: 3.162

Review 6.  Structure-guided drug design: conferring selectivity among neuronal nicotinic receptor and acetylcholine-binding protein subtypes.

Authors:  Palmer Taylor; Todd T Talley; Zoran Radic'; Scott B Hansen; Ryan E Hibbs; Jian Shi
Journal:  Biochem Pharmacol       Date:  2007-08-03       Impact factor: 5.858

Review 7.  Nicotinic agonists, antagonists, and modulators from natural sources.

Authors:  John W Daly
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

8.  Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors.

Authors:  Neal Innocent; Phil D Livingstone; Arik Hone; Atsuko Kimura; Tracey Young; Paul Whiteaker; J Michael McIntosh; Susan Wonnacott
Journal:  J Pharmacol Exp Ther       Date:  2008-07-29       Impact factor: 4.030

9.  PACAP/PAC1R signaling modulates acetylcholine release at neuronal nicotinic synapses.

Authors:  Phyllis C Pugh; Selwyn S Jayakar; Joseph F Margiotta
Journal:  Mol Cell Neurosci       Date:  2009-12-01       Impact factor: 4.314

10.  Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.

Authors:  Reena Halai; Richard J Clark; Simon T Nevin; Jonas E Jensen; David J Adams; David J Craik
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.